chrisvoncsefalvay/vaers-outcomes huggingface dataset:
This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (Delay getting second dose due to illness) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 30-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ILLNESS (Delay getting second dose due to illness). At the time of the report, ILLNESS (Delay getting second dose due to illness) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Patient was not feeling well so told to delay her second dose. No concomitant medications were reported. No treatment information was provided by reporter. Patient received the call and stated that she never had Moderna and hung up the phone.   Most recent FOLLOW-UP information incorporated above includes: On 19-Jul-2021: Follow-up received on 19-JUL-2021 and contains no new information
Information has been received from a lawyer regarding a case in litigation concerning a male patient of unknown age. No information was received regarding the patient's past medical history, concurrent conditions, or concomitant medication. On an unknown date in 2008, the patient was inoculated with the ZOSTAVAX (lot number, dosage and route of administration not provided), as recommended for routine adult health maintenance for the prevention of shingles. The ZOSTAVAX did not prevent shingles as intended, and the patient subsequently contracted a persistent strain of herpes zoster, also known as shingles and other complications. On or about 16-JAN-2016, the patient was treated for a blistering vesicular outbreak that was diagnosed as severe herpes zoster. The outcome of the events is unknown. As a direct and proximate result of ZOSTAVAX vaccine, and/or despite receiving ZOSTAVAX for the long-term prevention of shingles, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, and pain and suffering, and other damages. Additional information has been requested.
Information has been received from a company representative concerning her 18 month old nephew with no pertinent medical history or allergies who on 07 Apr 2006 was vaccinated with a dose of Varivax. Several hours after vaccination, the patient developed a rash. It was reported that it was unknown whether the vaccine was Varivax or Proquad. The patient was seen by a pediatrician. The patient's symptoms resolved with the use of calamine lotion. The outcome is recovered. No product quality complaint was involved. Additional information is not expected.
Myalgia, Fever & NauseaVomiting Narrative:  Chills and clammy without Fever, Nausea, GI symptoms. The Chills and Clamminess were improved with the use of Acetaminophen.
Patient presented to Pharmacist approximately 1 hours after vaccination with red face, arms, & legs. RPh immediately administered 50mg diphenhydramine IM and monitored patient for next hour. The redness steadily decreased, patient went home. He called later to inform RPh that he was feeling much better.
Arm soreness; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Arm soreness) in a 72-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030L20A) for COVID-19 vaccination.     Concomitant products included MIRTAZAPINE (REMERON), CLONAZEPAM, LEVOTHYROXINE, TAMSULOSIN, PANTOPRAZOLE, HYDROCODONE BITARTRATE, PARACETAMOL (HYDROCODONE/APAP) and ROSUVASTATIN for an unknown indication.    On 26-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Jan-2021, the patient experienced PAIN IN EXTREMITY (Arm soreness). On 27-Jan-2021, PAIN IN EXTREMITY (Arm soreness) had resolved.        mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged.       Treatment information was not provided. Patient reported that in trying to get a third dose on 17AUG2021 the patient accidentally received a dose of the Pfizer COVID-19 vaccine   This case was linked to MOD-2021-289836 (Patient Link).
Patient was given the Hep B vaccine on the day of his birth and again on the next day, April 8th and 9th.  He was hospitalized a week later due to mustard colored thick vomiting and a blockage was suspected at the time.  He was given his third Hep B vaccine at his four month check up and that is when I found out about his two in two day immunizations. The discharge summary received on 3/23/04 indicates previously coded intestinal obstruction was ruled out. Please add jaundice, bacterial eye infection, and tender, hard abdomen.  Per annual report-I don't know because facility says now that the shot was never given.  Funny, since I have a record of it.  Facility needs to stand up for their mistakes and they are just making excuses.  I'm not happy and I am glad you are following up on the case!
headache; chills; sore muscles all over; sore throat with redness; sore throat with redness; sore arm; metallic taste still present; sore; fatigue; This is a spontaneous report from a contactable consumer (patient). A 43-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) (Lot Number: EN6204) via an unspecified route of administration, administered in right arm on 16Mar2021 at 12:00 (at 43 years old) as single dose for COVID-19 immunization. There were no other vaccinations within 4 weeks prior to the first dose of BNT162B2. There was no relevant medical history. The patient had no known allergies. Concomitant medications included meloxicam, triamterene, omeprazole, estradiol, and zolpidem; all from unspecified date for unspecified indication. The patient did not have COVID-19 prior to vaccination. The patient was tested for COVID-19 post vaccination. The patient experienced sore and fatigue, both on 16Mar2021 at 12:00. The patient had metallic taste still present on 25Mar2021. The patient also had headache, chills, sore muscles all over, sore throat with redness, sore throat with redness, and sore arm; all on 26Mar2021. The events resulted in physician office and emergency room visit. The events were considered medically significant. The course of event was reported as follows: The patient reported that day after the first shot, she was sore and fatigued. Then 9 days after started with a metallic taste. On Day 10, severe headache, chills, fatigue, sore arm, sore muscles all over, sore throat with redness. All lasted for 48 hours. At the time of report, metallic taste still present and the patient was still recovering from the side effects. In 10 days after getting shot, 3 doctor visits, 2 rapid test (both were negative), negative flu test, negative strep test, intravenous (IV) with 2 bags of fluids meds, a third covid shot and blood work. The doctor sent off to have checked and awaiting on those results to come back at the time of report. The patient also added "I was told 16 strands that the test were testing for and it's believed I have one of those strands. With a negative result I've missed so much already what is my employer doesn't pay me?" (as reported). Three nasal swabs (rapid) on unspecified dates were negative. On 23Mar2021, blood test (regular test) was performed (pending results). On 26May2021, nasal swab (rapid) was negative. On 27Mar2021, blood test (rapid) was negative. Treatment received included IV with 2 bags with ibuprofen and nausea medications. Outcome of the events was recovering.
She denied further AE; Patients were administered MMRII that underwent multiple temperature excursion since 12-MAY-2020; This spontaneous report was received from a registered nurse concerning an unreported age and gender patient. No information was provided regarding the patient's pertinent medical history, concomitant medications, and previous drug reactions or allergies.  On 22-SEP-2020, the patient was vaccinated with 0.5 milliliters (ml) of improperly stored measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live recombinant human albumin (rHA) (M-M-R II) as prophylaxis (lot number R028526, expiration date 04-OCT-2020, which was determined to be valid) (formulation, dose number, vaccination scheme frequency, route and anatomical location of administration were not reported) (product storage error).   The involved vaccine underwent multiple temperature excursions; the warmest reported temperature was 21.6 grades Celsius (C) for a cumulative time of 15 hours and 30 minutes, as recorded by a data logger. No additional adverse events (AE) were reported.  This is one of 14 reports received from the same reporter.; Sender's Comments:  US-009507513-2108USA000260: US-009507513-2108USA000263: US-009507513-2108USA000259: US-009507513-2107USA008497: US-009507513-2108USA000262: US-009507513-2108USA000271: US-009507513-2108USA000264: US-009507513-2108USA000265: US-009507513-2108USA000266: US-009507513-2108USA000267: US-009507513-2108USA000268: US-009507513-2108USA000269: US-009507513-2108USA000270:
PT reports starting symptoms at 11:30 p.m. after receiving vaccine at 1 p.m. the same day.  She reports frequent urination "all night," nausea, dry heaves, chills and teeth chattering.    Of note is that her sister reported similar symptoms after receiving her vaccine the same day.
Info has been received from a health professional concerning a 13 year old female with no pre-existing allergies, birth defects or medical conditions who on 8/16/96 was vaccinated SC with a 1st dose of varicella virus vaccine live (lot 616338/0559D). There was no illness at the time of vaccination. On 1/8/06, the pt was dx'd with varicella. At the time of the report, the pt had active disease. Additional info has been requested.
Patient was given Janssen Covid 19 Vaccine on 11/8/2021. Patient waited 15 minutes in the pharmacy before being rung out at the register for his vaccination. After signing for his prescription (after waiting 15 minutes in the pharmacy), patient stated that he felt dizzy and was going to sit for a little while longer. When walking back to the pharmacy waiting area, the patient had a fainting spell and collapsed on the floor. When responding to the patient, he was awake and alert. Patient states that he did not hit his head when falling. Patient was able to sit up and was given water and a cold/wet paper towel per his request. After a few minutes, the patient was able to get up and stated he felt better. Pharmacist had patient take blood pressure, which was recorded at 110/76. Patient declined further medical care. The patient was here alone and stated that there was no one in the area to call for a ride. Pharmacy staff offered to call friend/relative for assistance or to call 911 for patient - the patient declined. The patient stated that he felt well enough to drive home and was instructed to call the pharmacy upon arrival home. Patient called around 7 PM on 11/8/21 stating that he was doing okay and that he had made it home safely. Pharmacist will follow up with patient tomorrow (11/9/21).
This spontaneous report as received form a pharmacist via Company Representative concerning a female patient of unknown age. On an unknown date, the patient was vaccinated with a dose of ZOSTAVAX (dose, lot number and expiration date not reported), subcutaneous. It was reported that the patient developed an injection site reaction that was larger than normal after receiving ZOSTAVAX which included redness, swelling and warmth. Patient's outcome was unknown. The patient sought medical attention by talking to the pharmacy. Additional information has been requested.
Numbness and itchiness all over arms and legs. Lasted over 24 hours. One week after on left arm (where Tdap was inserted) a raised red inflamed area appeared and radiated heat. Area was approximately 3" in diameter. The next day, a flu-like cold appeared accompanied by numbness, tingleness and pain shooting through arms and legs. Small lumps found in legs along tibialis anterior and around ankle area. The pain makes it hard to perform normal ADL's.
02/06/22 presents to ED for "Extremity weakness". PMHx of "A fib, HTN, Hypothyroidism, CVA<HLD, Seizure"
At first there was pain and tingling all over body (head to toe) which last about 12 hours. Then there was headaches (pressure like) and feeling of brain fog. (Still to this day I have these issues) I was in and out the of hospital a few times with migraine headaches and pressure in head. Doctors were unable to find a cause for these headaches and pain. Tried a few different treatment options such as Advil, Aleve, and shot at the hospital.  No one confirmed it was the vaccine causing headaches, but there is no other known cause at this time.
Flu like symptoms for around 12 hours.   Mainly a chill and fever.    Felt run down the following weak but no symptoms now.
Red swollen itching and painful bump about 2 inch in diameter which occurred  a few days after injection.  It faded somewhat then reappeared along with itching again two weeks later.
8-9-19 pain in left arm where she got injection. Decreased range of motion of shoulder and swelling of left chest. Low grade temp of 99. Pain with using arm to apply pressure like holding lof of bread to cut it.
Fever, sweats,soreness and redness at the injection site.  headache. Broke out in a full body sweat to where the sheets were soaked.
Site: Pain at Injection Site-Mild, Systemic: Dizziness / Lightheadness-Severe, Systemic: Fainting / Unresponsive-Severe, Systemic: Flushed / Sweating-Severe, Additional Details: Patient received the Moderna vaccine then went to her car then returned to the store to use the restroom within a period of 15 minutes. Upon walking to the rest room in the back of the store. Patient fainted and momentarilty lost consciousness. Patient hit head on the floor. Post event. Ice packs and water were provided and patient was assessed for any further symptoms.
Post vax, the patient developed varicella. Subsequently, the patient recovered. Unspecified medical attention was sought.
"felt like punch in arm"; bad mosquito bite; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA ("felt like punch in arm") and VACCINATION SITE PAIN (bad mosquito bite) in a 57-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 022C24C) for COVID-19 vaccination.     The patient's past medical history included Biopsy tendon (BICEP REPAIR SURGERY) and Vasectomy. Concomitant products included LISINOPRIL, DULOXETINE and PRAVASTATIN for an unknown indication.    On 07-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-May-2021, the patient experienced MYALGIA ("felt like punch in arm") and VACCINATION SITE PAIN (bad mosquito bite). The patient was treated with TRAMADOL at a dose of 2 PILLS and TRAMADOL at an unspecified dose and frequency. At the time of the report, MYALGIA ("felt like punch in arm") and VACCINATION SITE PAIN (bad mosquito bite) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication of Multivitamins(NOS)  taken as reported by the patient.    This case was linked to MOD-2021-214603 (Patient Link).
This spontaneous report as received from a physician refers to a patient of unknown age and gender. On 07-APR-2015, the patient was vaccinated with improperly stored PNEUMOVAX (lot # K024976 exp date 09-JUN-2016) (dose and route not reported). The temperature and time of excursion was 1.11 C for 64 hours. The vaccine status was reported as "in excursion", the storage criteria and the vaccine excursion were reported as "Refrigerator (R)". No adverse effects were reported. This is one of several reports received from the same source. Additional information has been requested.
Information ahs been received from a registered nurse concerning a 14 year old female with a "cardiac history" and no drug reactions/allergies who on 26-FEB-2007 was vaccinated intramuscularly in the right arm one dose of VAQTA (lot # 656320/1281F). Concomitant therapy included GARDASIL, ADACEL and MENACTRA. On 26-FEB-2007 the patient experienced an injection site reaction from the vaccination. The reaction consisted of redness, swelling and pain in the right arm. The patient sought unspecified medical attention. The patient was seen by the physician on 01-MAR-2007 and was still having the symptoms. No diagnostic laboratory tests were performed. At the time of the report the patient was recovering. There was no product quality complaint. The records of testing prior to release of the lot in question have been rechecked and found to be satisfactory. The lot met requirements of the CBER and was released by the regulatory agency. Additional information has been requested.
Information has been received from a physician who on an unspecified date was vaccinated with zoster vaccine live (Oka/Merck). Subsequently, "2 weeks after the injection" she developed an inflammatory mass on her tricep that had warmth, redness and pain. Her axillary lymph nodes were also swollen, which lasted for about 2 weeks. Unspecified medical attention was sought. It was unspecified if lab studies were performed. The patient recovered on an unspecified date. There was no product quality complaint involved. Additional information has been requested.
pimply rash on the face; rash on the face; This case was reported by a consumer via call center representative and described the occurrence of pimples in a 76-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 6th July 2020, the patient received the 1st dose of Shingrix. On 8th July 2020, 2 days after receiving Shingrix, the patient experienced pimples and rash. On an unknown date, the outcome of the pimples and rash were not recovered/not resolved.   It was unknown if the reporter considered the pimples and rash to be related to Shingrix.  Additional details were provided as follows: The patient received Shingrix and developed a pimply rash on the face. The reporter did not consent to follow up.; Sender's Comments:  US-GLAXOSMITHKLINE-US2020129042:
Information has been received from a nurse concerning a 13 year old female with AMOXICILLIN allergy who on 05-JUL-2009 was vaccinated with the first "standard dose" IM of GARDASIL (lot #657621/0387U). There were no concomitant medications. The nurse reported that the patient had a "reaction" after receiving the GARDASIL. The patient mentioned that she did not "feel good" after vaccination. The outcome was reported as recovered (date not reported). The patient did not seek medical attention. Additional information information has been requested.
Mother reported child presenting with a bulging fontanelle Saturday the 8th.  She stated it was the size of a goose egg with child presenting with fever of 100.1.  She telephoned the child's provider to discuss concerns.  Child still presenting with bulging fontanelle on Sunday with no fever at last report that day.
01/15/21 Staff Nurse was called to the Observation room by Nurse at 1050.  Nurse stated that at 1045, two minutes before the timer would expire,  patient complained of felling heaviness in her neck and chest. Using a number scale for evaluation, she rated her heaviness a 4/10.   She Placed her on the dyanmat and recorded vital signs of BP: 136/96, HR: 82, RR:20 and Sao2 of 97% on room air.  RN stated she medicated patient with 60 mg Fexofenadine by mouth.  When another RN arrived, patient was resting in a chair, alert and oriented x3.  No distress noted.  Patient complained of heaviness in her neck.  She denied chest pain, shortness of breath, dizziness or headache.  Heart rate 72 and regular.  Respirations even and nonlabored.  Patient was given juice and crackers and asked to stay in chair for 30 minute stay/observation. Nurse observed her from this time on.  Nurse stated the heaviness was much less at 1058, rated 2/10 on a number scale.  Vital signs:  108/76, 76, 18, 97%.  At 11:13, Patient rated her heaviness at 1/10.  Vital signs: 130/81, 71, 18, 97%.  At 11:35, patient states the heavy feeling is gone rated 0/10.  Vital signs: 128/59, 74, 16, 98% on room air. Patient stood without dizziness.  Gait was steady upon discharge from observation room.:RN
HA which began approximately 20 mins after administration (0810 AM on 2/3).  Localized injection site pain began later that evening around 1700 (on 2/3)..  Enlarged right supraclavicular lymph node noted around 1100 on 2/4 with increased arm pain (mostly located in shoulder and increased with movement).  Localized injection site reaction noted as redness and  a painful knot at same time.   Right side of neck sore and tender-to-touch, but not able to palpate any other lymph nodes.    As of this submission,  Supraclavicular lyonnaise node still swollen, arm pain with movement (at shoulder) minimal , and injection site still  painful with a knot.
Information has been received from a consumer concerning her daughter who was vaccinated with the third dose of GARDASIL.  In January 2009 ("a couple of days ago"), the patient experienced an oily discharge that appeared to be green in color leaking from her rectum.  At the time of this report, the outcome was unknown.  The patient did not seek medical attention and the reporter stated that she would be contacting her daughter's doctor.  No further information is available.
Seen in office on 11/21/02. Presents with papules, fluid filled on thighs. Mom reports they are itchy. Temp 97.6. Papules were not spreading.
Five hours after the anthrax vaccine was administered (two "pimples" (acne) started forming under the lower lip, above the chin. The pimples are deep under the skin an painful when touched. The following day, the pimples grew and produced white heads. Two days after the vaccine, three more pimples appeared over the upper lip, under the nose. On th e morning of the third day after the vaccine, the pimples above the lip where larger with white heads, and extremely painful. The entire upper lip area was swollen to twice the normal size. A topical antibiotic was given by the health unit. Patient is waiting a few more days to see if the pimples dissipate.
I began experiencing tinnitus, a high pitched sound which has not ceased since late January, shortly after my 2nd COVID vaccine.
I woke up with sudden and extreme neck pain in the back of neck.  The back of neck was swollen w/ a visible lump.  Very sore to move head or turn in anyway.  Even the vibration of walking caused pain at one point.  There were shooting pains radiating down my right arm.  Took a dose of methylprednisolone that did nothing.  Pain has continued on and off since despite numerous tests and 6 months of physical therapy.
R09.02 HYPOXIA 6/4/2021 LEFT FEMUR PATHOLOGICAL FX, INIT R09.02 HYPOXIA 6/4/2021 ADENOCARCINOMA, PROSTATE R09.02 HYPOXIA 6/4/2021 ADENOCARCINOMA, PROSTATE
Breakthrough case admission after 2 vaccines; Moderna 3/25/21 Lot# 047A21A; Moderna 4/22/21 Lot# 043B21A.